Fleetwood Onsite Conference Recording - Conference presentation capture Contact  |  My Account  |  Cart Contents  |  Checkout   
  Home »

Previous Product  Product 109 of 109  Next Product   Manafacturer

 
 *Complete MGH February 2017 "Substance Use Disorders: A Comprehensive Review and Update 2017" Conference MP3 Audio Recordings Package $189.00   
Select Format:

Full Conference Audio Recordings - Plus Slides

Available on CD-ROM or USB Flash Drive

This package features audio recordings of all sessions recorded exactly as is happened at the Massachusetts General Hospital Psychiatry Academy "Substance Use Disorders: A Comprehensive Review and Update 2017" Conference, held February 20-22, 2017 in Lake Buena Vista, FL.

Includes MP3 files of every session. Listen on your computer or fill your iPod or favorite MP3 player with all the live audio from every session. This package allows you to review presentations and is a lasting valuable resource.

BONUS: Also includes slides of sessions in PDF format.

 


INCLUDES ALL OF THE PRESENTATIONS FROM THE CONFERENCE:

Item Monday, February 20, 2017
  Neuroscience
28461 Neurobiology of Addiction   James A. Morrill, MD, PhD
28462 Genetics of Substance Use Disorders   Robert R. Althoff, MD, PhD
28463 Neuroscience Panel Discussion   David H. Rubin, MD; James A. Morrill, MD, PhD; Robert R. Althoff, MD, PhD
  Empirically Based Methodologies I
28464 Motivational Interviewing   John F. Kelly, PhD
28465 CBT   John F. Kelly, PhD
28466 Contingency Management   Robert R. Althoff, MD, PhD
28467 Empirically Based Methodologies I Panel Discussion  
Timothy E. Wilens, MD; John F. Kelly, PhD; Robert R. Althoff, MD, PhD
  Developmental Perspectives
28468 Childhood Precursors   Robert R. Althoff, MD, PhD
28469 Adolescence   Timothy E. Wilens, MD
28470 Developmental PerspectivesPanel Discussion   
David H. Rubin, MD; Robert R. Althoff, MD, PhD; Timothy E. Wilens, MD
  Pharmacotherapy I
28471 Managing Complicated Withdrawal   Shamim H. Nejad, MD
28472 Nicotine   James A. Morrill, MD, PhD
28473 Methamphetamine, Cocaine, Stimulants   Timothy E. Wilens, MD
28474 Pharmacotherapy I Panel Discussion   Timothy E. Wilens, MD; Shamim H. Nejad, MD; James A. Morrill, MD, PhD
  Comorbidity I
28475 Mood Disorders   Shamim H. Nejad, MD
28476 Hepatitis C / HIV   James A. Morrill, MD, PhD
28477 Anxiety Disorders   Shamim H. Nejad, MD
28478 Comorbidity I Panel Discussion   Timothy E. Wilens, MD; Shamim H. Nejad, MD; James A. Morrill, MD, PhD
Item Tuesday, February 21, 2017
  Recovery Oriented Systems of Care
28479 Recovery Models of Care   John F. Kelly, PhD
28480 Treating Addiction as a Chronic Disease   Sarah E. Wakeman, MD
28481 Recovery Oriented Systems of Care Panel Discussion  
Timothy E. Wilens, MD; John F. Kelly, PhD; Sarah E. Wakeman, MD
  Marijuana, Synthetics, and Triple C-Legal and Illegal
28482 Medical Marijuana   Timothy E. Wilens, MD
28483 Management of Marijuana Addiction   Martha T. Kane, PhD
28484 OCT: Synthetics and Triple-C   Timothy E. Wilens, MD
28485 Marijuana, Synthetics, and Triple C-Legal and Illegal Panel Discussion 
Laura G. Kehoe, MD, MPH; Timothy E. Wilens, MD; Martha T. Kane, PhD
  Empirically Based Methodologies II
28486  Trauma Informed Care   Martha T. Kane, PhD
28487 Self-Help Treatments   John F. Kelly, PhD
28488 Empirically Based Methodologies II Panel Discussion
Laura G. Kehoe, MD, MPH; John F. Kelly, PhD; Martha T. Kane, PhD
  Comorbidity II
28489 ADHD   Timothy E. Wilens, MD
28490 Pain   Laura G. Kehoe, MD, MPH
28491 Comorbidity II Panel Discussion   Sarah E. Wakeman, MD; Timothy E. Wilens, MD; Laura G. Kehoe, MD, MPH
Item Wednesday, February 22, 2017
  Inpatient
28492 Substance Use Disorder Initiative: MGH Model   Sarah E. Wakeman, MD
28493 Inpatient Nursing in Addiction Care   Christopher J. Shaw, NP
28494 InpatientPanel Discussion   Laura G. Kehoe, MD, MPH; Christopher J. Shaw, NP; Sarah E. Wakeman, MD
  Empirically Based Methodologies III
28495 Screening and Assessment   Christopher J. Shaw, NP
28496 Harm Reduction   Sarah E. Wakeman, MD
28497 Empirically Based Methodologies III Panel Discussion
Laura G. Kehoe, MD, MPH; Sarah E. Wakeman, MD; Christopher J. Shaw, NP
  Pharmacotherapy II
28498 Opioids   Sarah E. Wakeman, MD
28499 Alcohol   Laura G. Kehoe, MD, MPH
28500 Sedatives and Hypnotics   David H. Rubin, MD
28501 Pharmacotherapy II Panel Discussion   David H. Rubin, MD; Sarah E. Wakeman, MD; Laura G. Kehoe, MD, MPH

 





Customers who bought this product also purchased

*MGH March 2017 "Attention Deficit Hyperactivity Disorder Across the Life Span 2017" Conference MP3 Audio Recordings Package

 Copyright © 2020 Fleetwood Onsite Conference Recording


Fleetwood Facebook Page Follow us on Twitter Fleetwood on YouTube